Biomolecular Markers of Bone Metastasis
Recruiting
N/A
Interventional Study
Bone Metastasis
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 18 and older
- Sex
- Any
- Study type
- Interventional
- Purpose
- Prevention
- Participants needed
- 160 (estimated)
- Sponsor
- IRCCS Azienda Ospedaliero-Universitaria di Bologna · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The goal of this clinical trial is to characterize the biomolecular profile of bone metastases to define the predisposing profiles of bone metastasis, in patients with breast or lung or renal carcinomas or of the gastroenteric or prostate tract with bone metastasis.
The main question it aims to answer is:
Is it possible to predict the progression of bone metastasis by identifying biomarkers as r…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Age \>= 18 years
* Patients with breast or lung or renal or gastroenteric tract or prostate with bone metastases
* Patients who knowingly express willingness to participate in the study after signing the written informed consent
Exclusion Criteria:
* None
Contacts